People. Experience. Thought Leadership.

Many of the nation’s leading healthcare organizations come to PwC for business insights and solutions. From assurance, audit and tax to the full spectrum of advisory services, our people provide outstanding industry knowledge, firsthand experience, and professional skills that range the entire healthcare spectrum. 

For every client, and for every project, we tap into some of the brightest minds and the most relevant industry wisdom, connecting a comprehensive network of resources to provide powerful strategies that help you succeed in a competitive and changing marketplace.

More of PwC’s perspective

Thought leadership

Customizing healthcare

Customizing healthcare

Read article

Customizing healthcare

Customizing healthcare

The current issue of View Magazine includes two health related articles: how customizing healthcare could transform employer benefits in a postreform world and what patient-centered healthcare means and how personalized medicine is addressing these challenges.

Achieving global supply chain visibility

Achieving global supply chain visibility

Read article

Achieving global supply chain visibility

Behind the numbers: Medical cost trends 2011

Global pharmaceutical outsourcing has become increasingly prevalent, but is creating a complex and risky supply chain environment that has pharmaceutical and life sciences executives on high alert. A major study co-sponsored by PwC indicates there are forces driving the industry to develop a supply chain that is more extended, globally dispersed and virtual. However, the ability to control the safety, efficacy and effectiveness of products will continue to be a challenge until the industry implements systems that can provide real time, global visibility into the supply chain, including practices and information from suppliers, distributors, shippers, and contract manufacturers.

Case studies

Intellectual Property Protection

Read case study

Intellectual Property Protection

View webcast

Web page

A non-profit biomedical research organization sought third party consultation and negotiation assistance to license a potential new drug application for an existing compound with multiple potential indications. Their objective was to negotiate and secure a solid up-front payment for the license and establish a significant royalty rate.

Research and development portfolio management

Read case study

Research and development portfolio management

View webcast

Web page

A major pharmaceutical company identified a need to improve its research & development (R&D) portfolio evaluation and prioritization process. Seeking advice, the company turned to the pharmaceutical specialists in PwC's UK valuation & strategy’s group for help.

Multimedia downloads

Prospering in a post-health reform world

View webcast

Prospering in a post-health reform world

View webcast

Webcast

On Friday, April 23rd PwC hosted a webcast, "Health reform: Prospering in a post-reform world". The one hour program hosted by PwC's Health Research Institute explains meaningful details of the reform legislation and the potential ramifications for businesses and the health industries.

Health reform in Massachusetts: a model for the U.S.?

View webcast

Health reform in Massachusetts: a model for the U.S.?

View webcast

Webcast

It’s no coincidence that proposed health reform legislation builds on principles of Massachusetts health reform. Controversial before its enactment, and still a subject of heated debate outside of the state, Massachusetts health reform has gained wide approval from Massachusetts voters. Three years into the project, the Massachusetts Health Connector has reduced uninsured individuals to 2.7% of the population.